Symmetric Dimethylarginine is Altered in Patients After Myocardial Infarction and Predicts Adverse Outcomes.
Aleksandra GaseckaPiotr SzwedKarolina JasińskaOliwia FidaliAleksandra KłębukowskaCeren EyiletenMarek PostulaAgnieszka SzarpakTomasz MazurekGrzegorz OpolskiKrzysztof Jerzy FilipiakMarcin UfnalPublished in: Journal of inflammation research (2021)
Plasma concentration of dimethylarginines differs between patients with AMI and healthy volunteers. The study's novel finding is that SDMA is an independent predictor of MACE during a 3.5 year follow-up period after AMI.